Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children

doi:10.3748/wjg.v18.i40.5729

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 40

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4330)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

358

HTML

3539

Figures (1-1)

229

Tables (1-2)

204

Sum=4330

Oct 28, 2012 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (43)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Oct 28, 2012; 18(40): 5729-5733
Published online Oct 28, 2012. doi: 10.3748/wjg.v18.i40.5729

Table 1 Comparison of age, gender, duration of illness and gluten intake in patients receiving vaccine booster by the intradermal or intramuscular route

	Intradermal	Intramuscular	P value
Age (yr)	10.45 ± 6.7¹	9.3 ± 5.9¹	NS²
Gender (male/female)	10/20	9/19	NS³
Duration of illness (yr)	6.15 ± 4.1¹	7.5 ± 4.6¹	NS²
Gluten Intake (yr)	5.3 ± 3.7¹	4.6 ± 3.2¹	NS²

NS: Not significant.

¹mean ± SD;

²Mann-Whitney U-test;

³Fisher exact test.

Citation: Leonardi S, Praticò AD, Lionetti E, Spina M, Vitaliti G, Rosa ML. Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children. World J Gastroenterol 2012; 18(40): 5729-5733
URL: https://www.wjgnet.com/1007-9327/full/v18/i40/5729.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i40.5729